Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients

Regnery S, Adeberg S, Dreher C, Oberhollenzer J, Meissner JE, Goerke S, Windschuh J, Deike-Hofmann K, Bickelhaupt S, Zaiss M, Radbruch A, Bendszus M, Wick W, Unterberg A, Rieken S, Debus J, Bachert P, Ladd M, Schlemmer HP, Paech D (2018)

Publication Status: Published

Publication Type: Journal article, Original article

Publication year: 2018

Journal

Oncotarget Impact Journals

Publisher: Impact Journals LLC

Book Volume: 9

Pages Range: 28772-28783

Journal Issue: 47

DOI: 10.18632/oncotarget.25594

Authors with CRIS profile

Moritz Zaiß

Involved external institutions

Universitätsklinikum Heidelberg DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE) Max-Planck-Institut für biologische Kybernetik / Max Planck Institute for Biological Cybernetics DE Germany (DE)

How to cite

APA:

Regnery, S., Adeberg, S., Dreher, C., Oberhollenzer, J., Meissner, J.E., Goerke, S.,... Paech, D. (2018). Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients. Oncotarget, 9(47), 28772-28783. https://doi.org/10.18632/oncotarget.25594

MLA:

Regnery, Sebastian, et al. "Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients." Oncotarget 9.47 (2018): 28772-28783.

BibTeX: Download